1. FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer. Issue 6 (12th May 2017) Authors: He, Lingfeng; Luo, Libo; Zhu, Hong; Yang, Huan; Zhang, Yilan; Wu, Huan; Sun, Hongfang; Jiang, Feng; Kathera, Chandra S.; Liu, Lingjie; Zhuang, Ziheng; Chen, Haoyan; Pan, Feiyan; Hu, Zhigang; Zhang, Jing; Guo, Zhigang Journal: Molecular oncology Issue: Volume 11:Issue 6(2017) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer. Issue 9 (September 2017) Authors: He, Lingfeng; Luo, Libo; Zhu, Hong; Yang, Huan; Zhang, Yilan; Wu, Huan; Sun, Hongfang; Jiang, Feng; Kathera, Chandra S.; Liu, Lingjie; Zhuang, Ziheng; Chen, Haoyan; Pan, Feiyan; Hu, Zhigang; Zhang, Jing; Guo, Zhigang Journal: Molecular oncology Issue: Volume 11:Issue 9(2017) Page Start: 1302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗